Stroke, depression and dementia: These are associated with micro-failures in brain communication. FAU researchers are looking at what exactly happens in these situations and are hoping to identify possible ways of preventing permanent brain damage and speeding up the healing processes.
FAU researchers and their colleagues at the University of Bayreuth investigated whether an artificial silk protein developed in the laboratory could be suitable for engineering cardiac tissue.
Neuroscientists have joined forces with human geneticists at Otto von Guericke University in Magdeburg to develop a new approach to the treatment of rare genetic conditions such as Noonan syndrome.
In future, researchers in Erlangen will take into account a little-noted factor in the development of diseases: physics.
The Digital Health Innovation Platform (d.hip) was established by an alliance between university medicine, industry, and science for the purpose of accelerating the digitalization of medicine and healthcare.